CD19+ tumor-infiltrating B-cells activated CD4+ tumor-infiltrating T-cells in the TMB of BLCA and acted as an independent prognostic factor for post-surgery survival and adjuvant chemotherapy benefits of BLCA patients (41). This evidence concerns the gene CD19 and neoplasm.